The healthcare and care services company Ambea controls, following the completion of its offer for all shares in industry peer Humana, the equivalent of 97.99 percent of the capital and votes in the company. This is stated in a press release.
Ambea will not extend the acceptance period for the offer any further, and the offer has therefore ended. The extended acceptance period expired on 14 October. A compulsory buyout of the remaining shares in Humana now awaits.
As previously announced, Humana’s shares will be delisted from Nasdaq Stockholm, with the last trading day on 27 October.
